Abstract:Aims of the study: Kanglaite (KLT) is a useful antitumor drug with proven effects when combined with chemotherapy, radiotherapy or surgery. We hypothesize that KLT has antitumor activity and immunomodulatory effects in Lewis lung carcinoma.Materials and methods: C57BL/6 mice with Lewis lung carcinoma were divided into four groups: the control group (C), cisplatin group (1 mg/kg, DDP), low KLT group (6.25 ml/kg body weight [L] and high KLT group (12.5 ml/kg body weight [H]). T cell proliferation was determined by the mu assay. Nuclear factor-kappa B (NF-kappa B), inhibitor kappa B alpha (I kappa B alpha), I kappa B kinase (IRK) and epidermal growth factor receptor (EGFR) levels were measured by western blotting. An enzyme-linked immunosorbent assay was used to analyze the expression of interleukin-2 (IL-2).Results: Intraperitoneal KLT significantly inhibited the growth of Lewis lung carcinoma, and the spleen index was significantly higher in the L and H groups than in the C group. KLT stimulated T cell proliferation in a dose-dependent manner. Treatment with KLT at either 6.25 or 12.5 ml/kg decreased the level of NF-kappa B in the nucleus in a dose-dependent manner, and KLT markedly decreased the expression of I kappa B alpha, IKK and EGFR in the cytoplasm of tumor cells and overall. IL-2 was significantly increased in the supernatant of splenocytes in the H group.Conclusions: These results demonstrate that KLT has pronounced antitumor and immunostimulatory activities in C57BL/6 mice with Lewis lung carcinoma. These may affect the regulation of NF-kappa B/I kappa B expression, in addition to cytokines such as IL-2 and EGFR. Further work needs to investigate the relevant signaling pathway effects, but our findings suggest that KLT may be a promising antitumor drug for clinical use. (C) 2012 Elsevier Ireland Ltd. All rights reserved.

Effect of KLT on proliferation of spleen lymphocyte of tumor bearing L 1210 Leukemia mice

The effect of the transfer of lak cells, combined with alloimmunization, on the pulmonary metastases of rat mammary carcinoma

Antitumor Activity and Immunomodulatory Effects of the Intraperitoneal Administration of Kanglaite in Vivo in Lewis Lung Carcinoma

Antitumor Activity of Kanglaite Injection in Animals with Transplanted Tumors

Experimental study on antileukemia effects of anti-CD3/interleukin-2 costimulated killer cells and interleukin-2 liposomes plus kappa-selenocarrageenan

Effect of Kanglaite Injection on Plasma Osteopontin of Human Colon Carcinoma Liver Metastasis Model in Nude Mice

A Research on the KangLaiTe Lnjection in Treating the Liver Metastasis

Study on Therapy of Leukemia Through Proliferated NK Cell Induced by Low-Dose Radiation in Nude Mice

Mechanism and Anti-liver Tumor Metastasis Activity of the Kang Lai Te Injection

Antitumor Action of Kanglaite Injection against Xenograft Human Tumor Models

Influence of Kanglaite injection on expression of proliferating cell nuclear antigen in Lewis lung cancer mice

The Effect of Kanglaite Injection (KLT) on the Proliferation and Telomerase Activity of Rat Mesangial Cells

Experimental Study of Effect of Huanglian Jiedu Decoction on Immunifaction in Tumor-bearing Mice

[Experimental Study of LAK and Activated NK Cells Affecting Hematopoiesis in Mice].

Regulatory effect of Kanglaite Injection on immune function in patients with non small cell lung cancer treated with chemotherapy

Activation of NK Cells by Transfecting IL-2 And/or IL-12 Gene into Spleen in Rats with Induced Liver Cancer

EFFECT OF BUPLEURUM-KUNMINGENSE POLYSACCHARIDES ON THE WEIGHT OF SPLEEN, THYMUS, PROLIFERATION OF LYMPHOCYTE AND PLAQUE-FORMING CELL IN MICE

ANTITUMOR ACTIVITY OF KANGLAITE INJECTION

Effect of Rhndpk-Α Protein on Proliferation and Cell Cycle of Normal Mice Spleen Lymphocytes

Effect of human rIL-2 on tumor cytotoxicity murine splenic cells

Effect of Total Flavonoids from Lysimachia Clethroides Duby on Human Leukemia HL-60 Cell Xenograft in Nude Mice